​

Funding Round

Series B - Harbinger Health

Series B - Harbinger Health

Investment Firm

Overview

Harbinger Health is a biotechnology company that develops a two-tier testing model for the detection of early cancer with a blood test.

Announced Date

Sep 28, 2023

Funding Type

Series B

Highlights

Location

United States, North America

Social

Investor Lead

Flagship Pioneering

Flagship Pioneering

Flagship Pioneering is a debt and early_stage_venture and late_stage_venture and post_ipo and private_equity and venture firm.

Participant Investors

5

Investor Name
Participant InvestorModi Ventures
Participant InvestorPartners Investment
Participant InvestorCatalyst
Participant InvestorPictet Private Equity Investors S.A.
Participant InvestorFlagship Pioneering

Round Details and Background

Harbinger Health raised $140000000 on 2023-09-28 in Series B

Harbinger Health is a biotechnology company that develops a two-tier testing model for the detection of early cancer with a blood test.

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Sep 28, 2023
Series B - Harbinger Health
6-140.0M
Dec 07, 2021
Series A - Harbinger Health
1-50.0M

Recent Activity

There is no recent news or activity for this profile.